Maha Othman: Redefining Hemostasis Through AI-Enabled Peptide Engineering
Maha Othman, Co-Chairman SSC on Disseminated intravascular coagulopathy at International Society on Thrombosis and Haemostasis, shared
Seminars in Thrombosis and Hemostasis‘s post on LinkedIn, adding:
“Delighted to see this published.
Proud of my mentee Thomas Kazmirchuk and collaborator Ashkan Golshani
Look forward to continuing this research to drive innovation towards understanding of disease pathophysiology, diagnosis, and management, especially for the rare bleeding disorders!”
Seminars in Thrombosis and Hemostasis shared a post on LinkedIn about a recent article by Thomas Kazmirchuk et al., adding:
“Excited to share this insightful article on how AI-driven peptide design is shaping the future of hemostasis and precision medicine for bleeding disorders.
A promising step toward more targeted and personalized therapies.”
Title: Designing the Future of Hemostasis
Authors: Thomas D. D. Kazmirchuk , Jiashu Wang, Janice Corbette, Zein Al Abideen Hammad, Maha Othman, Ashkan Golshani
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH
-
Sep 18, 2026, 15:54Swapnil Pawar: Why Aren’t We Using Cryopreserved Platelets Everywhere Yet?
-
Sep 18, 2026, 15:37Abdul Mannan: Evaluating Longitudinal Platelet Trends Beyond Standard Reference Intervals
-
Sep 18, 2026, 15:30Peter A. Everts։ Platelet Phenotype May Hold the Key to More Consistent PRP Therapy
-
Sep 18, 2026, 15:25Brandon Temple: Turning Personal Experience Into Advocacy for wAIHA Research
-
Sep 18, 2026, 15:01A. M. Thirugnanam: Antiplatelet Discontinuation and the Risk of Stent Thrombosis